Riskpilot← Back to searchSign inGet full accessRavmarker Aktiebolag
ABDissolvedOrg 5591874283Manufacture of pharmaceutical preparations · NACE 2120Est. 20180 employees
Revenue 2020
SEK 0
EBITDA margin
—
-31% vs 2019
Equity ratio
97.4%
Financial strength
Net profit 2020
SEK -245K
-58% vs 2019
| Revenue | SEK 0 | — |
| EBITDA | SEK -200K | -31% |
| Net profit | SEK -245K | -58% |
| Total assets | SEK 616K | -19% |
| Equity | SEK 600K | -19% |
| Employees | 0 | — |
Legal name
Ravmarker Aktiebolag
Org number
5591874283
Legal form
Aktiebolag
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
19 december 2018
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Company purpose
Bolaget ska bedriva utveckling och försäljning av medicinskt diagnostiska och terapeutiska produkter, samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 |
|---|---|---|
| Revenue | 0 | 0 |
| Staff expenses | — | — |
| EBITDA | −153 | −200 |
| Depreciation & amort. | −2 | −45 |
| EBIT | −155 | −245 |
| Net financials | — | — |
| Profit before tax | −155 | −245 |
| Tax | −0 | −0 |
| Net profit | −155 | −245 |
| Item | 2019 | 2020 |
|---|---|---|
| Total assets | 761 | 616 |
| Equity | 745 | 600 |
| Long-term debt | 0 | 0 |
| Short-term debt | 16 | 16 |
| Total debt | 16 | 16 |
EBITDA margin
-20000000.0%
This company
15.8%
Market median
-126582378% vs market
20192020
Equity ratio
97.4%
This company
38.2%
Market median
+155% vs market
20192020
Return on equity
-40.8%
This company
18.4%
Market median
-322% vs market
20192020
Net profit margin
-24500000.0%
This company
8.1%
Market median
-302469236% vs market
20192020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192020
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20192020
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-12-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
JM Chief Auditor | Chief Auditor | 2021 – 2022 |
JM Chief Auditor | Chief Auditor | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
| Deputy Board Member | 2020 – 2022 | |
| Chairman | 2020 – 2020 | |
| Chairman | 2020 – 2021 | |
| Deputy Board Member | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ravmarker Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johanna Margareta Eklöf | Chief Auditor | 0 companies |
| Jessica Maria Semb | Chief Auditor | 0 companies |
| Anna Katharina Gimlander | Deputy Board Member | 0 companies |
| Mats Gustaf Rånby | Chairman | 0 companies |
| Rikard Albert Rodén | Chairman | 0 companies |
| Ingrid Marie Danielsson Rånby | Deputy Board Member | 0 companies |